LD-2 disclosure · Registration

BOBBIE BABY, INC.

1st Quarter (Jan 1 - Mar 31) · 2024Posted Feb 7, 2024Filing document ↗LDA record ↗

Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.

Client

Name: BOBBIE BABY, INC.
Description: Infant formula company
Location: California · United States of America

Registrant

Firm: CORBIN STRATEGIES LLC
Location: Washington, District of Columbia, United States of America

Lobbying activities

3 issues

Agriculture
Advocate for issues related to the infant formula shortage, including improving access and nutrition standards for infants, growing manufacturing opportunities for small domestic infant formula producers, and monitoring trade issues; and maternal health issues (H.R.3305/S.1606, Momnibus Act;S.1714/H.R.3481, FAMILY Act).
Lobbyistsms KIMBERLY CORBIN
Covered position (ms KIMBERLY CORBIN): Sen. Adv., H. Rules Chairman Jim McGovern; U.S. Jt. Econ. Cmte Staff Dir., Sen. Heinrich; Staff Dir., Finance Subcmte on Health and Sen. Legis. Counsel, Sen. Debbie Stabenow; Legis. Counsel, Sen. Mark Udall; Legis. Counsel, Rep. Jerry Nadler
Health Issues
Advocate for issues related to the infant formula shortage, including improving access and nutrition standards for infants, growing manufacturing opportunities for small domestic infant formula producers, and monitoring trade issues; and maternal health issues (H.R.3305/S.1606, Momnibus Act;S.1714/H.R.3481, FAMILY Act).
Lobbyistsms KIMBERLY CORBIN
Covered position (ms KIMBERLY CORBIN): Sen. Adv., H. Rules Chairman Jim McGovern; U.S. Jt. Econ. Cmte Staff Dir., Sen. Heinrich; Staff Dir., Finance Subcmte on Health and Sen. Legis. Counsel, Sen. Debbie Stabenow; Legis. Counsel, Sen. Mark Udall; Legis. Counsel, Rep. Jerry Nadler
Trade (domestic/foreign)
Advocate for issues related to the infant formula shortage, including improving access and nutrition standards for infants, growing manufacturing opportunities for small domestic infant formula producers, and monitoring trade issues; and maternal health issues (H.R.3305/S.1606, Momnibus Act;S.1714/H.R.3481, FAMILY Act).